Core Viewpoint - The controlling shareholder and former chairman of Meihua Biological, Meng Qingshan, has been sentenced to three years in prison with a five-year probation for manipulating the securities market, following a fine of 122 million yuan [1][3][9]. Group 1: Legal Proceedings - Meng Qingshan was convicted of securities market manipulation by the Langfang Intermediate People's Court in Hebei Province [3][8]. - The court's decision includes a three-year prison sentence, which is suspended for five years, and a fine that will be offset by previously paid administrative penalties [3][8]. - Meng has not held any position in the company since his retirement in January 2017, and the incident is classified as a personal matter, not affecting the company's operations [3][8]. Group 2: Background of the Case - The case stems from actions taken in 2013 and 2014, where Meng and others were found to have manipulated stock prices to ensure the success of a non-public stock issuance [10][11]. - The investigation revealed that Meng and his associates engaged in practices that led to significant illegal gains, amounting to 196 million yuan for a trust fund involved in the stock issuance [11][12]. - The China Securities Regulatory Commission (CSRC) previously imposed a fine of 122 million yuan on Meng and his associates for their actions, which included a ten-year ban from the securities market [12]. Group 3: Company Impact - As of November 7, 2023, Meihua Biological's stock closed at 11.52 yuan per share, with a market capitalization of 32.3 billion yuan [5]. - The company has stated that its production and operational activities remain normal despite the legal issues surrounding its former chairman [3][8].

Group 1 - Fangzheng Technology's subsidiary plans to invest 1.364 billion yuan in an AI expansion project in Chongqing to quickly increase production capacity [1] - The current production capacity at the Chongqing base cannot meet customer order demands, necessitating this investment [1] - The expansion aims to strategically optimize product structure and enhance the company's ability to meet the needs of high-end clients in AI, cloud computing, and big data sectors [1] Group 2 - Huadian Technology signed a contract worth approximately 3.415 billion yuan for a 1 million kW offshore wind power project, which constitutes about 45.29% of the company's latest audited revenue [2] - This contract is expected to have a positive impact on the company's operating performance [2] Group 3 - ST Huayun applied to revoke other risk warnings after receiving a penalty notice from the China Securities Regulatory Commission for false reporting from 2018 to 2022 [3] - The company has completed a review and found no conditions warranting the risk warning, thus meeting the criteria for revocation [3] Group 4 - Meihua Biological's controlling shareholder was sentenced to three years in prison (suspended for five years) for manipulating the securities market, but this matter does not affect the company's operations [4] - The company confirmed that its production and business activities remain normal despite the legal issues surrounding the shareholder [4] Group 5 - Shanghai Xiba's board members are under investigation for suspected short-term trading, but this investigation is personal and will not significantly impact the company's daily operations [5] Group 6 - Changcheng Technology terminated plans for a change in control due to a lack of consensus on key matters, and its stock will resume trading on November 10, 2025 [6] Group 7 - Hefei China reported a 23.91% year-on-year decline in consolidated revenue for the period from January to October 2025, totaling 587 million yuan [8] Group 8 - Various companies are involved in significant project wins and collaborations, including Rayco Defense acquiring minority stakes in a subsidiary and several companies winning contracts for large-scale projects [13]

Core Points - The controlling shareholder and former chairman of Meihua Biological, Meng Qingshan, has been sentenced to three years in prison with a five-year probation for manipulating the securities market [2][5] - Following a penalty of 122 million yuan, the court also imposed a fine on Meng Qingshan [2][5] - As of November 7, Meihua Biological's stock closed at 11.52 yuan per share, with a market capitalization of 32.3 billion yuan [2] Summary by Sections - **Legal Proceedings**: Meng Qingshan received a written notification from the Intermediate People's Court of Langfang, Hebei Province, regarding his conviction for manipulating the securities market, resulting in a three-year prison sentence and a fine [5][6] - **Background of the Case**: Meng Qingshan retired from his position in the company in January 2017 and has not held any official role since then, only exercising shareholder rights at meetings [5][6] - **Investigation Details**: The China Securities Regulatory Commission (CSRC) initiated an investigation into Meng Qingshan and the then-secretary of the board, Yang Huixing, for their involvement in manipulating the stock price during a non-public offering in 2013 [6][7] - **Manipulation Tactics**: The investigation revealed that Meng Qingshan and Yang Huixing engaged in actions to ensure the success of the non-public offering by manipulating stock prices and controlling information dissemination [7][8] - **Financial Impact**: The illegal gains from their actions amounted to 196 million yuan for the involved trust, with actual losses of 140 million yuan incurred by a shareholder [7][8]

据悉，孟庆山于2025年3月被提起公诉。梅花生物表示，孟庆山自2017年1月退休后已不在公司担任任何 职务，仅作为股东在股东大会层面行使股东权利，上述事项仅涉及孟庆山个人，与公司无关，目前公司 生产经营活动一切正常。该事项不会对公司的股权结构、公司的法人治理及生产经营构成影响。 北京商报讯（记者 马换换 王蔓蕾）11月7日晚间，梅花生物（600873）披露公告称，公司当日接控股股 东孟庆山书面通知，其收到河北省廊坊市中级人民法院出具的《刑事判决书》，判决如下：被告人孟庆 山犯操纵证券市场罪，判处有期徒刑三年，缓刑五年，并处罚金（缓刑考验期限从判决确定之日起计 算，罚金以已缴纳的行政处罚罚款折抵）。 ...

新京报贝壳财经讯 11月7日，梅花生物公告，公司控股股东孟庆山收到河北省廊坊市中级人民法院出具 的《刑事判决书》，判决孟庆山犯操纵证券市场罪，判处有期徒刑三年，缓刑五年，并处罚金(缓刑考 验期限从判决确定之日起计算，罚金以已缴纳的行政处罚罚款折抵)。孟庆山自2017年1月退休后已不在 公司担任任何职务，上述事项仅涉及孟庆山个人，与公司无关，目前公司生产经营活动一切正常。该事 项不会对公司的股权结构、法人治理及生产经营构成影响。 ...

Core Viewpoint - The controlling shareholder of Meihua Biological, Meng Qingshan, has been sentenced to three years in prison with a five-year probation for manipulating the securities market, but this matter is personal and does not affect the company's operations or governance structure [1] Group 1 - Meng Qingshan received a criminal judgment from the Intermediate People's Court of Langfang City, Hebei Province, for the crime of manipulating the securities market [1] - The sentence includes three years of imprisonment, with a five-year probation period, and a fine that will be offset by previously paid administrative penalties [1] - Meng Qingshan has not held any position in the company since his retirement in January 2017, indicating that the issue is unrelated to the company's current management [1] Group 2 - The company confirms that its production and operational activities are normal despite the legal issues faced by its controlling shareholder [1] - There is no expected impact on the company's equity structure, corporate governance, or operational activities due to this personal matter [1]

孟庆山先生自2017年1月退休后已不在公司担任任何职务，仅作为股东在股东大会层面行使股东权利， 上述事项仅涉及孟庆山先生个人，与公司无关，目前公司生产经营活动一切正常。该事项不会对公司的 股权结构、公司的法人治理及生产经营构成影响。 梅花生物（600873）(600873.SH)发布公告，2025年3月，公司控股股东孟庆山先生被提起公诉。今日， 公司接控股股东孟庆山先生书面通知，其收到河北省廊坊市中级人民法院出具的《刑事判决书》，判决 如下：被告人孟庆山犯操纵证券市场罪，判处有期徒刑三年，缓刑五年，并处罚金(缓刑考验期限从判 决确定之日起计算，罚金以已缴纳的行政处罚罚款折抵)。 ...

孟庆山先生自2017年1月退休后已不在公司担任任何职务，仅作为股东在股东大会层面行使股东权利， 上述事项仅涉及孟庆山先生个人，与公司无关，目前公司生产经营活动一切正常。该事项不会对公司的 股权结构、公司的法人治理及生产经营构成影响。 智通财经APP讯，梅花生物(600873.SH)发布公告，2025年3月，公司控股股东孟庆山先生被提起公诉。 今日，公司接控股股东孟庆山先生书面通知，其收到河北省廊坊市中级人民法院出具的《刑事判决 书》，判决如下：被告人孟庆山犯操纵证券市场罪，判处有期徒刑三年，缓刑五年，并处罚金(缓刑考 验期限从判决确定之日起计算，罚金以已缴纳的行政处罚罚款折抵)。 ...

人民财讯11月7日电，梅花生物（600873）11月7日公告，公司控股股东孟庆山收到河北省廊坊市中级人 民法院出具的《刑事判决书》，判决孟庆山犯操纵证券市场罪，判处有期徒刑三年，缓刑五年，并处罚 金(缓刑考验期限从判决确定之日起计算，罚金以已缴纳的行政处罚罚款折抵)。孟庆山自2017年1月退 休后已不在公司担任任何职务，上述事项仅涉及孟庆山个人，与公司无关，目前公司生产经营活动一切 正常。该事项不会对公司的股权结构、法人治理及生产经营构成影响。 ...

关于控股股东被提起公诉的进展公告 公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 证券代码：600873 证券简称：梅花生物 公告编号：2025-057 今日，公司接控股股东孟庆山先生书面通知，其收到河北省廊坊市中级人民 法院出具的《刑事判决书》，判决如下：被告人孟庆山犯操纵证券市场罪，判处 有期徒刑三年，缓刑五年，并处罚金（缓刑考验期限从判决确定之日起计算，罚 金以已缴纳的行政处罚罚款折抵）。 2025 年 3 月，公司控股股东孟庆山先生被提起公诉，详见公司于 2025 年 3 月 17 日发布在上海证券交易所网站上的《关于控股股东被提起公诉的公告》（公 告编号：2025-029）。 孟庆山先生自 2017 年 1 月退休后已不在公司担任任何职务，仅作为股东在 股东大会层面行使股东权利，上述事项仅涉及孟庆山先生个人，与公司无关，目 前公司生产经营活动一切正常。该事项不会对公司的股权结构、公司的法人治理 及生产经营构成影响。 梅花生物科技集团股份有限公司 特此公告。 梅花生物科技集团股份有限公司董事会 2025 年 11 ...